Recommendation Edges Pomalyst Closer To Japan Launch
This article was originally published in PharmAsia News
Executive Summary
Japan has issued approval recommendations and other regulatory decisions for a batch of drugs including Celgene's myeloma therapy Pomalyst, which now looks set to be approved and possibly launched in the country within the next few months.